Björn-Oliver Gohlke

According to our database, Björn-Oliver Gohlke authored at least 13 papers between 2013 and 2022.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2022

SuperPred 3.0: drug classification and target prediction - a machine learning approach.

Kathleen Gallo, Andrean Goede, Robert Preissner, Björn-Oliver Gohlke

Nucleic Acids Res., 2022

2021

PROMISCUOUS 2.0: a resource for drug-repositioning.

Kathleen Gallo, Andrean Goede, Andreas Eckert, Barbara Moahamed, Robert Preissner, Björn-Oliver Gohlke

Nucleic Acids Res., 2021

2018

SuperDRUG2: a one stop resource for approved/marketed drugs.

Vishal B. Siramshetty, Andreas Eckert, Björn-Oliver Gohlke, Andrean Goede, Qiaofeng Chen, Prashanth Devarakonda, Saskia Preissner, Robert Preissner

Nucleic Acids Res., 2018

mVOC 2.0: a database of microbial volatiles.

Marie Chantal Lemfack, Björn-Oliver Gohlke, Serge M. T. Toguem, Saskia Preissner, Birgit Piechulla, Robert Preissner

Nucleic Acids Res., 2018

Exploring Activity Profiles of PAINS and Their Structural Context in Target-Ligand Complexes.

Vishal B. Siramshetty, Robert Preissner, Björn-Oliver Gohlke

J. Chem. Inf. Model., 2018

2017

Chemoinformatische Datenintegration zur Analyse und Vorhersage von Interaktionen von kleinen organischen Molekülen mit deren Biomolekülen (Chemoinformatic data integration to analyse and predict drug-target interactions)

Björn-Oliver Gohlke

PhD thesis, 2017

2016

WITHDRAWN - a resource for withdrawn and discontinued drugs.

Vishal B. Siramshetty, Janette Nickel, Christian Omieczynski, Björn-Oliver Gohlke, Malgorzata N. Drwal, Robert Preissner

Nucleic Acids Res., 2016

CancerResource - updated database of cancer-relevant proteins, mutations and interacting drugs.

Björn-Oliver Gohlke, Janette Nickel, Raik Otto, Mathias Dunkel, Robert Preissner

Nucleic Acids Res., 2016

2015

Super Natural II - a database of natural products.

Priyanka Banerjee, Jevgeni Erehman, Björn-Oliver Gohlke, Thomas Wilhelm, Robert Preissner, Mathias Dunkel

Nucleic Acids Res., 2015

2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib.

Björn-Oliver Gohlke, Tim Overkamp, Anja Richter, Antje Richter, Peter T. Daniel, Bernd Gillissen, Robert Preissner

BMC Bioinform., 2015

2014

SuperPred: update on drug classification and target prediction.

Janette Nickel, Björn-Oliver Gohlke, Jevgeni Erehman, Priyanka Banerjee, Wen Wei Rong, Andrean Goede, Mathias Dunkel, Robert Preissner

Nucleic Acids Res., 2014

SuperPain - a resource on pain-relieving compounds targeting ion channels.

Björn O. Gohlke, Robert Preissner, Saskia Preissner

Nucleic Acids Res., 2014

2013

SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relations.

Joachim von Eichborn, Mathias Dunkel, Björn O. Gohlke, Sarah C. Preissner, Michael F. Hoffmann, Jakob M. J. Bauer, J. Douglas Armstrong, Martin H. Schaefer, Miguel A. Andrade-Navarro, Nicolas Le Novère, Michael D. R. Croning, Seth G. N. Grant, Pim van Nierop, August B. Smit, Robert Preissner

Nucleic Acids Res., 2013